Reprint

Recent Advances in Understanding of the Role of Synuclein Family Members in Health and Disease

Edited by
October 2023
188 pages
  • ISBN978-3-0365-8938-1 (Hardback)
  • ISBN978-3-0365-8939-8 (PDF)

This book is a reprint of the Special Issue Recent Advances in Understanding of the Role of Synuclein Family Members in Health and Disease that was published in

Biology & Life Sciences
Medicine & Pharmacology
Summary

In this Special Issue, we have compiled data and opinions from leading scientists to demonstrate the recent advances in the study of function and dysfunction of synucleins. These proteins are involved in multiple normal and pathological molecular processes and consequently have various effects on cell biology of the nervous system. Three members of the synuclein family share many structural properties and have an overlapping pattern of expression and intracellular distribution in the developing and adult nervous system, which point to functional redundancy within the family. However, each synuclein has its own functions which are not shared with the two other family members, and there are certain cellular mechanisms and pathways in which these functions could be antagonistic rather than synergistic.

Format
  • Hardback
License
© 2022 by the authors; CC BY-NC-ND license
Keywords
prenatal alcohol exposure; synucleins; alcohol consumption; free-choice; hippocampus; midbrain; mRNA expression; α-synuclein; rats; synucleins; dopaminergic neuron; MPTP; knockout mice; Parkinson’s disease; alpha-synuclein; SH-SY5Y; hiPSCs; organoid; aggregation; synucleinopathy; blood–brain barrier; microglia; astrocytes; overexpression; mutation; Lewy body; Parkinson’s disease; synucleinopathies; Parkinson’s disease; multiple system atrophy; dementia with Lewy bodies; deep brain stimulation; focused ultrasound; gene therapy; surgical techniques; synucleins; dopamine; electroencephalogram; frequency spectrum; α-, β- and γ-synuclein; Parkinson’s disease; epigenetic; protein aggregation; SNARE-complex; protein trafficking; phytochemicals; synucleinopathies; methylation; histones; γ-synuclein; autoantibodies; glaucoma; dopamine; α2-macroglobulin; tear fluid; intraocular pressure; SARS-CoV-2 spike RBD domain; alpha-synuclein; amyloid aggregation; post-COVID-19 neurodegeneration; SARS-CoV-2 vaccine; Parkinson’s disease; depression; Parkinson’s disease; α-synuclein; serotonin; raphe nuclei; synucleinopathies; Lewy bodies diseases; Parkinson’s disease; E46K-SNCA; cognition; nonmotor; clustering analysis; multimodal MRI; n/a